StemoniX provides manufacturing and drug screening services and development partnerships:
Human iPS Cell Manufacturing
“Human iPS Cells From Millions to Billions”
We offer high volume, economical manufacturing platforms to expand human iPS cells with lot sizes exceeding 1 billion cells, differentiate to cardiac and neuronal cells, structure into physiologically relevant microtissues, and plate onto high throughput screening plates.
Differentiation-Ready Offering:
- Human iPSCs
- Human Neural Progenitor Cells
Discovery as a Service
Custom Assay and Disease Model Development
Leverage StemoniX expertise to develop physiologically-relevant human cell-based assays to improve your drug discovery research and screening outcomes.
Drug testing for drug discovery and high throughput screening, safety pharmacology, and investigative toxicology.
Our platforms include kinetic cellular assays with high throughput plate and multimode plate readers, high content imaging, and electrophysiology
